RECURRENT MATURE T-CELL AND NK-CELL NON-HODGKIN LYMPHOMA

Clinical trials for RECURRENT MATURE T-CELL AND NK-CELL NON-HODGKIN LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT MATURE T-CELL AND NK-CELL NON-HODGKIN LYMPHOMA trials appear

Sign up with your email to follow new studies for RECURRENT MATURE T-CELL AND NK-CELL NON-HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 2 Completed 1

New combo attack on Tough-to-Treat cancers

Disease control Completed

This study tested whether combining a type of immunotherapy (pembrolizumab) with targeted radiation could help patients whose aggressive non-Hodgkin lymphoma had come back or stopped responding to other treatments. The goal was to see if the combination could shrink tumors and co…

Matched conditions: RECURRENT MATURE T-CELL AND NK-CELL NON-HODGKIN LYMPHOMA

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

RECURRENT MATURE T-CELL AND NK-CELL NON-HODGKIN LYMPHOMA

Get alerted when new RECURRENT MATURE T-CELL AND NK-CELL NON-HODGKIN LYMPHOMA trials appear

New combo attack on Tough-to-Treat cancers